Department of Public Health Medicine, Faculty of Medicine, Universiti Kebangsaan Malaysia, Cheras, Kuala Lumpur, Malaysia.
Ministry of Health Malaysia, Federal Government Administrative Centre, Putrajaya, Malaysia.
PLoS One. 2023 Nov 16;18(11):e0294260. doi: 10.1371/journal.pone.0294260. eCollection 2023.
Influenza is a contagious respiratory illness that can cause life-threatening complications among high-risk groups. Estimating the economic burden of influenza is essential to guide policy-making on influenza vaccination programmes, especially in resource-limited settings. This study aimed to estimate the economic burden of influenza on older adults (those aged ≥60 years) in Malaysia from the provider's perspective.
The main data source in this study was the MY-DRG Casemix database of a teaching hospital in Malaysia. Cases with principal and secondary diagnoses coded in the International Classification of Diseases version 10 (ICD-10) as J09, J10.0, J10.1, J10.8, J11.0, J11.1, J11.8, J12.8, and J12.9, which represent influenza and its complications, were included in the study. The direct cost of influenza at all severity levels was calculated from the casemix data and guided by a clinical pathway developed by experts. The effect of the variations in costs and incidence rate of influenza for both the casemix and clinical pathway costing approaches was assessed with sensitivity analysis.
A total of 1,599 inpatient and 407 outpatient influenza cases were identified from the MY-DRG Casemix database. Most hospitalised cases were aged <18 years (90.6%), while 77 cases (4.8%) involved older people. Mild, moderate, and severe cases comprised 56.5%, 35.1%, and 8.4% of cases, respectively. The estimated average annual direct costs for managing mild, moderate, and severe influenza were RM2,435 (USD579), RM6,504 (USD1,549), and RM13,282 (USD3,163), respectively. The estimated total annual economic burden of influenza on older adults in Malaysia was RM3.28 billion (USD782 million), which was equivalent to 10.7% of the Ministry of Health Malaysia budget for 2020. The sensitivity analysis indicated that the influenza incidence rate and cost of managing severe influenza were the most important factors influencing the total economic burden.
Overall, our results demonstrated that influenza imposes a substantial economic burden on the older Malaysian population. The high cost of influenza suggested that further efforts are required to implement a preventive programme, such as immunisation for older people, to reduce the disease and economic burdens.
流感是一种传染性呼吸道疾病,可导致高危人群出现危及生命的并发症。从政策制定者的角度评估流感的经济负担对于流感疫苗接种计划至关重要,尤其是在资源有限的环境中。本研究旨在从提供者的角度估计马来西亚老年人(60 岁及以上)的流感经济负担。
本研究的主要数据来源是马来西亚一所教学医院的 MY-DRG Casemix 数据库。将主要和次要诊断编码为国际疾病分类第 10 版(ICD-10)J09、J10.0、J10.1、J10.8、J11.0、J11.1、J11.8、J12.8 和 J12.9 的病例纳入研究,这些编码代表流感及其并发症。根据专家制定的临床路径,从 casemix 数据中计算出所有严重程度的流感直接成本。使用敏感性分析评估成本和流感发病率变化对 casemix 和临床路径成本计算方法的影响。
从 MY-DRG Casemix 数据库中总共确定了 1599 例住院和 407 例门诊流感病例。大多数住院病例年龄<18 岁(90.6%),而 77 例(4.8%)涉及老年人。轻度、中度和重度病例分别占病例的 56.5%、35.1%和 8.4%。管理轻度、中度和重度流感的平均年直接成本估计分别为 2435 令吉(579 美元)、6504 令吉(1549 美元)和 13282 令吉(3163 美元)。估计马来西亚老年人流感的年总经济负担为 32.8 亿令吉(7.82 亿美元),相当于马来西亚卫生部 2020 年预算的 10.7%。敏感性分析表明,流感发病率和管理重度流感的成本是影响总经济负担的最重要因素。
总体而言,我们的研究结果表明流感给马来西亚老年人群带来了巨大的经济负担。流感的高成本表明需要进一步努力实施预防计划,如为老年人接种疫苗,以减轻疾病和经济负担。